Roche to present new OCREVUS (ocrelizumab) data analyses showing significant reduction of disability progression in relapsing and primary progressive multiple sclerosis at the AAN Annual Meeting

Matt Turner
Patient Affordability

Liz Kane
Impactful Strategy

Amy Giles
Increasing Engagement

Brenda Snow
Authentic Patient Voice

Stacey Gandler
Brand Nourishment

Bud Bilanich
Success Coach

David Linetsky
Point-of-Care Marketing

Frank Burrell
Scientific Storytelling

Matthew Durham
Omnidynamic Marketing

Pat Purcell
Meeting Engagement

Daniel Sontupe
Market Access

Joey Cohen
Medication Adherence

Paul Theisen
Patient Acquisition

Suma Ramadas, PhD
Medical Affairs